Home / News
-
-
Abbott's RealTime IDH1 Assay has received approval from the US Food and Drug Administration as a companion diagnostic for Servier Pharmaceuticals' Tibsovo (ivosidenib) in patients with relapsed or refractory myelodysplastic syndrome, the FDA announced on Tuesday.2023-10-26View More
-
-
Shares of Thermo Fisher Scientific (TMO) slumped over 7% in early trading Wednesday after the maker of lab equipment and analytical instruments posted weaker-than-expected sales and cut its outlook for a second-straight quarter on slowing demand.2023-10-26View More
-
-
Listed companies with main IVD business in China have completed the disclosure of their financial results in the first half of 2023.2023-10-25View More
-
-
Quest Diagnostics Inc (DGX, Financial), a leading provider of diagnostic information services, released its Q3 2023 earnings report on October 24, 2023. Despite a decrease in overall revenues, the company's base business revenues showed growth, largely due to strength in their physician and hospital channels.2023-10-25View More
-
-
On October 24, 2023, Danaher Corp (DHR, Financial) released its Q3 2023 earnings report, revealing a net earnings of $1.1 billion, or $1.51 per diluted common share.2023-10-25View More
-
-
Foundation Medicine announced on Monday that it is expanding its partnership with Sequanta Technologies to provide its genomic profiling tests for research and oncology therapy development in China.2023-10-24View More
-
-
Switzerland's Roche (ROG.S) has agreed to pay an initial $7.1 billion to Roivant (ROIV.O) and Pfizer (PFE.N) for rights to a new inflammatory bowel disease drug, as it expands into new fields to offset falling oncology sales.2023-10-24View More
-
-
Roswell Park Cancer Center said this week that Agilent Technologies has licensed its blood cancer assay, PanHeme.2023-10-23View More
-
-
The World Health Organization on Thursday announced that it has published a fourth edition of its essential diagnostics list (EDL) adding tests for the hepatitis E virus and recommendations related to access to personal-use glucose monitoring devices.2023-10-23View More
-
-
China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.2023-10-24View More
-
-
Thermo Fisher Scientific and Boehringer Ingelheim said on Thursday that they have partnered to develop companion diagnostic tests to help identify patients with non-small cell lung cancer (NSCLC) with specific mutations who may benefit from emerging targeted therapies.2023-10-20View More
-
-
Group sales grow by 1% at constant exchange rates (CER) in the first nine months, showing a strong increase of 7% in the third quarter.2023-10-20View More
-
-
Oxford Nanopore Technologies PLC (LSE:ONT) has secured a £70 million investment from French in-vitro diagnostics (IVD) company bioM¨¦rieux, in exchange for a 3.5% stake.2023-10-19View More
-
-
By the end of 2022, the total number of medical and health institutions nationwide reached 1,032,918, an increase of 1,983 compared to the previous year.2023-10-19View More
-
-
Revvity and Danaher subsidiary Sciex said Tuesday that they have signed a distribution agreement that will improve the accuracy of mass spectrometry-based disease screening in newborns by combining Sciex's mass spectrometry instruments and Revvity's reagents.2023-10-19View More
-
-
Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2023.2023-10-19View More
-
-
As of October 12, 2023, a total of 231 breakthrough medical devices have been approved in China, including 24 IVD products.2023-10-18View More
-
-
Werfen has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Aptiva Connective Tissue Disease (CTD) Essential reagent.2023-10-18View More
-
-
Thermo Fisher Scientific Inc. (NYSE: TMO) (¡°Thermo Fisher¡±), the world leader in serving science, and Olink Holding AB (publ) (¡°Olink¡±) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions, today announced that their respective boards of directors have approved Thermo Fisher¡¯s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash.2023-10-18View More
-
-
China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.2023-10-17View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.